Advances in the basic and clinical applications of thymosin β₄

Bibliography

• Low TL, Hu SK, Goldstein AL. Complete amino acid sequence of bovine thymosin beta4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci USA 1981;78:1162-6
   PubMed Web of Science ®Google Scholar
• Hooper JA, McDaniel MC, Thurman GB, et al. Purification and properties of bovine thymosin. Ann N Y Acad Sci 1975;249:125-44
   PubMed Web of Science ®Google Scholar
• Goldstein AL, Goldstein AL. From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther 2009;9(5):593-608
   PubMed Web of Science ®Google Scholar
• Erickson-Viitanen S, Ruggieri S, Natalini P, et al. Thymosin beta10, a new analog of thymosin beta4 in mammalian tissues. Arch Biochem Biophys 1983;225:407-13
   PubMed Web of Science ®Google Scholar
• Baynard J, Hutchinson LM, Zetter BR. Thymosin beta-NB is the human isoform of rat thymosin beta15. Ann N Y Acad Sci 2007;1112:286-96
   PubMed Web of Science ®Google Scholar
• Wara DW, Goldstein AL, Doyle NE, et al. Thymosin activity in patients with cellular immunodeficiency. N Engl J Med 1975;292(2):70-4
   PubMed Web of Science ®Google Scholar
• Schafer LA, Goldstein AL, Gutterman JU, et al. In vitro and in vivo studies with thymosin in cancer patients. Ann N Y Acad Sci 1976;277:609-20
   PubMed Web of Science ®Google Scholar
• Schulof RS, Lloyd MJ, Ueno WM, et al. Phase II trial of thymosin fraction 5 in advanced renal cancer. J Biol Response Mod 1984;3(2):151-9
   PubMedGoogle Scholar
• Schulof RS, Simon GL, Sztein MB, et al. Phase I/II trial of thymosin fraction 5 and thymosin alpha one in HTLV-III seropositive subjects. J Biol Response Mod 1986;5(5):429-43
   PubMedGoogle Scholar
• Lavastida MT, Goldstein AL, Daniels JC. Thymosin administration in autoimmune disorders. Thymus 1981;2(4-5):287-95
   PubMedGoogle Scholar
• Sosne G, Qiu P, Christopherson PL, et al. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp Eye Res 2007;84:663-9
   PubMed Web of Science ®Google Scholar
• Qui P, Wheater MK, Sosne G. Thymosin beta 4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. FASEB J 2011;25:1815-26
   PubMed Web of Science ®Google Scholar
• Badamchian M, Fagarasan MO, Danner RL, et al. Thymosin beta4 reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int Immunopharmacol 2003;3:1225-33
   PubMed Web of Science ®Google Scholar
• Sosne G, Szliter EA, Barrett R, et al. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 2002;74:293-9
   PubMed Web of Science ®Google Scholar
• Young JD, Lawrence AJ, Mac Lean AG, et al. Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med 1999;5:1424-7
   PubMed Web of Science ®Google Scholar
• Wei C, Kumar S, Kim IK, et al. Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes. PLoS One 2012;7(8):e42586
   PubMed Web of Science ®Google Scholar
• Ehrlich HP, Hazard SW. Thymosin β4 affecting the cytoskeleton organization of the myofibroblasts. Ann N Y Acad Sci 2012;1269:74-8
   PubMed Web of Science ®Google Scholar
• Sosne G, Xu L, Prach L, et al. Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. Exp Cell Res 2004;293(1):175-83
   PubMed Web of Science ®Google Scholar
• Melinda KM, Goldstein AL, Kleinman HK. Thymosin beta4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J 1997;11:474-81
   PubMed Web of Science ®Google Scholar
• Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol 1999;113(3):364-8
   PubMed Web of Science ®Google Scholar
• Ehrlich HP, Hazard SWIII. Thymosin beta4 enhances repair by organizing connective tissue and preventing the appearance of myofibroblasts. Ann N Y Acad Sci 2010;1194:118-24
   PubMed Web of Science ®Google Scholar
• Treadwell T, Kleinman HK, Crockford D, et al. The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients. Ann N Y Acad Sci 2012;1270:37-44
   PubMed Web of Science ®Google Scholar
• Crockford D, Turjman N, Allan C, et al. Thymosin beta4: structure, function, and biological properties supporting current and future applications. Ann N Y Acad Sci 2010;1194:179-89
   PubMed Web of Science ®Google Scholar
• Kim S, Kwon J. Thymosin beta4 improves dermal burn wound healing via downregulation of receptor of advanced glycation end products in db/db mice. Biochim Biophys Acta 2014;1840(12):3452-9
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Kurpakus-Wheater M. Thymosin beta-4 and the eye: I can see clearly now the pain is gone. Ann N Y Acad Sci 2007;1112:114-22
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Ousler GW3rd, et al. Thymosin β4: a potential novel dry eye therapy. Ann N Y Acad Sci 2012;1270:45-50
   PubMed Web of Science ®Google Scholar
• Goldstein AL, Hannappel E, Sosne G, et al. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther 2012;12(1):37-51
   PubMed Web of Science ®Google Scholar
• Dunn SP, Heidemann DG, Chow CY, et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4. Ann N Y Acad Sci 2010;1194:199-206
   PubMed Web of Science ®Google Scholar
• Srivastava S, Srivarava D, Olson EN, et al. Thymosin beta4 and cardiac repair. Ann N Y Acad Sci 2010;1194:87-96
   PubMed Web of Science ®Google Scholar
• Rossdeutsch A, Smart N, Riley PR. Thymosin beta4 and Ac-SDKP: tools to mend a broken heart. J Mol Med 2008;86:29-35
   PubMed Web of Science ®Google Scholar
• Postrach J, Schmidt M, Thormann M, et al. Adeno-associated viral vector 2.9 thymosin β4 application attenuates rejection after heart transplantation: results of a preclinical study in the pig. Transplantation 2014;98(8):835-43
   PubMed Web of Science ®Google Scholar
• Morris DC, Cui Y, Cheung WL, et al. A dose-response study of thymosin β4 for the treatment of acute stroke. J Neurol Sci 2014;345(1-2):61-7
   PubMed Web of Science ®Google Scholar
• Xiong Y, Mahmood A, Meng Y, et al. Treatment of traumatic brain injury with thymosin beta4 in rats. J Neurosurg 2011;114:102-15
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang ZG, Morris D, et al. Neurological functional recovery after thymosin beta 4 trreatment in mice with experimental auto encephalomyelitis. Neuroscience 2009;164:1887-93
   PubMed Web of Science ®Google Scholar
• Wang L, Chopp M, Szalad A, et al. Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic mice. Neurobiol Dis 2012;48(3):546-55
   PubMed Web of Science ®Google Scholar
• Treadwell T, Kleinman HK, Crockford D, et al. The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients. Ann N Y Acad Sci 2012;1270:37-44
   PubMed Web of Science ®Google Scholar
• Guarnera G, DeRosa A, Camerini R. The effect of thymosin treatment of venous ulcers. Ann N Y Acad Sci 2010;1194:207-12
   PubMed Web of Science ®Google Scholar
• Fine JD. Epidermolysis bullosa: a genetic disease of altered cell adhesion and wound healing, and the possible clinical utility of topically applied thymosin beta4. Ann N Y Acad Sci 2007;1112:396-406
   PubMed Web of Science ®Google Scholar
• Reyes-Gordillo K, Shah R, Arellanes-Robledo J, et al. Protective effects of thymosin β4 on carbon tetrachloride-induced acute hepatotoxicity in rats. Ann N Y Acad Sci 2012;1269:61-8
   PubMed Web of Science ®Google Scholar
• Zuo Y, Chun B, Potthoff SA, et al. Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis. Kidney Int 2013;84(6):1166-75
   PubMed Web of Science ®Google Scholar
• Badamchian M, Damavandy AA, Damavandy H, et al. Identification and quantification of thymosin beta4 in human saliva and tears. Ann N Y Acad Sci 2007;1112:458-65
   PubMed Web of Science ®Google Scholar
• Li J, Yu L, Zhao Y, et al. Thymosin β4 reduces senescence of endothelial progenitor cells via the P13K/Akt/eNOS signal transduction pathway. Mol Med Rep 2013;7(2):598-602
   Web of Science ®Google Scholar
• Sosne G, Qui P, Goldstein AL, et al. Biological activities of thymosin beta 4 defined by active sites in short peptide sequences. FASEB J 2010;24(7):2144-51
   PubMed Web of Science ®Google Scholar